Our value creation model
We are an independent Group with a long-term vision thanks to our governance by a non-profit foundation: the Fondation Internationale de Recherche Servier.
Read more
The past financial year was marked by major progress in several of our areas of activity. We achieved — and in some cases exceeded — the ambitious targets we had set for ourselves for 2025, and we are on track to deliver on our 2030 ambition.
We are an independent Group with a long-term vision thanks to our governance by a non-profit foundation: the Fondation Internationale de Recherche Servier.
Read more
One of the keys to our success lies in our ability to meet the expectations of our stakeholders and to collaborate effectively with them.
Discover our stakeholders
Ten years. That is how long Servier has invested to successfully reinvent itself. Operational, organizational, managerial, cultural… This transformation is a springboard and lays the groundwork for the Group’s future: Servier 2030.
Read more
We have strengthened our relationship with patients and the organizations that represent them, so as to integrate their voices ever more closely at every stage of the medicine lifecycle. The goal: accelerate the development of tailored therapeutic solutions.
Read more
We focus on three therapeutic areas, we leverage the power of artificial intelligence and digital, and we are part of collaborative innovation models within global scientific ecosystems.
Read more
We are a global leader, ensuring our long-term sustainability through the efficiency and performance of our activities. We are recognized for our expertise across each of our therapeutic areas and in all our markets and our strength is built on an increasingly efficient organization.
Read more
Inspired by the same vocation and carried by strong values, our teams are the key to the Group’s lasting success.
Read more
During financial year 2024/2025, we achieved or exceeded most of the objectives we had set for 2025, particularly our revenue and EBITDA targets. We are seeing strong growth in oncology, confirming our commitment to this area and our determination to make our medicines available to an ever-growing number of patients worldwide.
Discover our financial results 2024/2025
We are committed to creating value for society as a whole by strengthening our contribution to global health, supporting healthcare systems, and innovating while minimizing our impact on the planet.
Read more
Measuring our social, societal, and environmental impact makes it possible to assess the Group’s non-financial performance—an essential condition for meeting our sustainability commitments.
Read more